CT DOSE Collaboratory

NCT03000751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 864080

Last updated 2024-03-08

Study results available
· View outcomes & findings →

Summary

This is a pragmatic stepped-wedge cluster randomized controlled trial to explore variation in doses used for diagnostic CT by pooling radiation dose data across diverse healthcare delivery systems.

To compare different strategies for lowering and optimizing dose and identify the barriers and facilitators to implementing successful dose optimization strategies and standardizing practice.

Conditions

  • Ionizing Radiation Exposure
  • Quality Improvement

Interventions

OTHER

Simple Audit Report

The simple audit provides comparison and feedback on radiation doses.

OTHER

Multi-Component Intervention

The multi-component intervention gives tailored feedback on needed changes plus guidance using quality improvement methods that facilitate organizational change. Provides access to experts, detailed audit, collaborative calls, and site visits (as needed).

OTHER

In-Person Meeting

Collaborator meeting with an emphasis on quality improvement.

Sponsors & Collaborators

  • University of California, Davis

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    collaborator OTHER
  • Center for Diagnostic Imaging

    collaborator OTHER
  • Community Health Network

    collaborator OTHER
  • Children's Mercy Hospital Kansas City

    collaborator OTHER
  • City of Hope Medical Center

    collaborator OTHER
  • Albert Einstein Healthcare Network

    collaborator OTHER
  • Universität Duisburg-Essen

    collaborator OTHER
  • East Texas Medical Center Regional Healthcare System

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • Henry Ford Health System

    collaborator OTHER
  • Huntsville Hospital Health System

    collaborator OTHER
  • Nicklaus Children's Hospital f/k/a Miami Children's Hospital

    collaborator OTHER
  • Mount Sinai Hospital, New York

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • Olive View-UCLA Education & Research Institute

    collaborator OTHER
  • Oxford University Hospitals NHS Trust

    collaborator OTHER
  • San Francisco VA Health Care System

    collaborator FED
  • St. Joseph Hospital of Orange

    collaborator OTHER
  • St. Luke's International Hospital, Japan

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • University of California, Irvine

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Rebecca Smith-Bindman, MD · University of California, San Francisco

  • Judy Yee, MD · San Francisco Veterans Administration

  • Tom Nelson, PhD · University of California, San Diego

  • Tony Seibert, PhD · University of California, Davis

  • Mayil Krishnam, MD · University of California, Irvine

  • Michael Flynn, PhD · Henry Ford Health System

  • Mary Cocker, MSc, Csci · Oxford University Hospitals NHS Trust

  • William Boswell, MD · City of Hope Medical Center

  • Sebastian Schindera, MD · University Hospital of Basel

  • Erin Bell, MHP · Community Health Network

  • Phuong-Anh Duong, MD · Emory University

  • Nima Kasraie, PhD, MSc · Children's Mercy Hospital Kansas City

  • Pavlina Pike, PhD · Huntsville Hospital

  • Luisa Cervantes, MD · Nicklaus Children's Hospital f/k/a Miami Children's Hospital

  • Joachim Wildberger, PhD · Maastricht University Medical Center

  • Michael Forsting, MD · University of Duisburg-Essen

  • Fady Kassem, PhD · St. Joseph Hospital of Orange

  • Darrell Fendrick, CT · East Texas Medical Center

  • Sugoto Mukherjee, MD · University of Virginia Health System

  • Brad Delman, MD · Icahn School of Medicine at Mount Sinai

  • Jodi Roehm · Center for Diagnostic Imaging

  • Anokh Pahwa, MD · Olive View - UCLA

  • Ryan Lee, MD, MBA · Einstein Medical Center

  • Jay Starkey, MD · St. Luke's International Hospital, Tokyo

  • Diana Miglioretti, PhD · University of California, Davis

  • Saravanabavaan Suntharalingam, MD · University of Duisburg-Essen

  • Sara Lewis, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000751 on ClinicalTrials.gov